FDA approves Ryzneuta by Evive Biotech for reducing febrile neutropenia in cancer patients
Evive Biotech, a global biopharmaceutical company and a subsidiary of Yifan Pharmaceutical Co. Ltd., along with New Jersey-based Acrotech Biopharma, a wholly-owned subsidiary of Aurobindo ... Read More
Spectrum Pharmaceuticals to divest seven oncology drugs in $300m deal with Acrotech Biopharma
In a major strategic move, Spectrum Pharmaceuticals, a prominent US-based biopharma company, has entered into a deal with Acrotech Biopharma, a subsidiary of Aurobindo Pharma ... Read More